WASHINGTONA minimallyinvasive heart valve procedure with a device made by Medtronic Inc was superior to traditional open surgery in extending the lives of patients with diseased aortic valves according to a new study After one year  of patients who received the Medtronic device called CoreValve were still alive compared with  of patients who underwent open surgery a statistically significant advantage the study found 